ENPP2 and metabolic dysfunction-associated steatotic liver disease: In particular, the study by Iwadare et al. [37] demonstrated that serum autotaxin levels represent a prognostic indicator of liver-related events in patients with NAFLD, supporting the clinical value of this biomarker.